Ultragenyx Pharmaceutical, Inc. (RARE)
35.97
-0.33
(-0.91%)
USD |
NASDAQ |
Dec 10, 12:08
Ultragenyx Pharmaceutical Total Liabilities (Quarterly): 1.174B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 9.212B |
| Amicus Therapeutics, Inc. | 638.39M |
| Geron Corp. | 318.68M |
| Ionis Pharmaceuticals, Inc. | 2.415B |
| Vertex Pharmaceuticals, Inc. | 7.544B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.190B |
| Shareholders Equity (Quarterly) | 9.159M |
| Debt to Equity Ratio | 94.24 |
| Current Ratio | 1.892 |
| Net Debt Paydown Yield | 0.44% |